Dr. Shyam Bishen is a senior healthcare executive with over 25 years of global experience in healthcare public-private partnership, strategy development, M&A, and business development. He comes to the Forum from Bill and Melinda Gates Foundation in Seattle where he was a regional/deputy director for seven years and was responsible for partnering to harness advances in healthcare to save lives. Before moving to Gates Foundation, he spent more than 20 years in private sector, and most recently headed up emerging markets strategy & innovation at Merck (MSD) in New Jersey as vice president and general manager. Prior to joining the corporate sector, Dr. Bishen was in academia and worked as an Assistant Professor at the Medical University of South Carolina in Charleston. He is qualified with a Ph.D. from the University of Newcastle and an MBA from Washington University in St. Louis.
With depression and anxiety estimated to cost the global economy over $1 trillion per year in lost productivity, policymakers and employers have long debated how workplaces can most effec...
The Serum Institute of India – the world's largest vaccine maker – has developed the country's first cervical cancer shot, which will reach the market soon, the company and India's govern...
The worldwide response to the COVID-19 pandemic highlighted how working together enabled us to deal urgently with the crisis. We should now learn from this multilateral approach to better...
Este artículo se publicó originalmente el 26 de mayo y fue revisado el 25 de julio de 2022.
快速浏览一下头条新闻，你会感觉现在无法对全球健康持乐观态度。新冠肺炎疫情持续影响着世界各地数以亿计的人，常规性的医疗服务和免疫接种运动正在努力赶上疫情累积的影响，甚至有人担心，俄罗斯入侵乌克兰造成的数百万人流离失所可能导致欧洲耐多药结核病（TB）等疾病的发病率上升。
A quick glance at the headlines does not suggest that now is the time for optimism around global health. The COVID-19 pandemic continues to impact hundreds of millions of people around th...
